Skip to content

Collegium Pharmaceutical

US · COLL #3535 by market cap Listed 2015
24.72 -0.49 -1.94%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 6 analysts

Buy
Avg price target 45.50 +84.1%
Price target rangecurrent 24.72
Low28.00
Avg45.50
High60.00
Buy 83% Hold 17% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Barclays -- Buy 41.00
2026-11-06 Piper Sandler -- Hold 28.00
2026-11-06 Truist Financial -- Buy 49.00
2026-11-06 H.C. Wainwright -- Buy 60.00
2026-10-15 Barclays -- Buy 48.00
2026-10-09 Oppenheimer -- Buy 50.00
2026-09-23 Oppenheimer -- Buy 50.00
2026-09-21 H.C. Wainwright -- Buy 60.00
2026-09-09 Truist Financial -- Buy 49.00
2026-09-09 Leerink Partners -- Buy 45.00
2026-08-18 Barclays -- Buy 48.00
2026-08-07 Piper Sandler -- Hold 43.00
2026-08-07 H.C. Wainwright -- Buy 60.00
2026-08-06 Needham -- Buy 46.00
2026-07-01 Barclays -- Buy 56.00
2026-05-14 Truist Financial -- Buy --
2026-05-12 Needham -- Buy 56.00
2026-05-12 Barclays -- Buy 56.00
2026-05-08 Truist Financial -- Buy --
2026-05-08 H.C. Wainwright -- Buy 60.00
2026-05-07 Needham -- Buy 56.00
2026-04-23 Piper Sandler -- Hold 44.00
2026-04-23 H.C. Wainwright -- Buy 60.00
2026-04-20 Piper Sandler -- Hold 44.00
2026-04-16 Needham -- Buy 56.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- ±22.34% +6.29% (in line)
2026/Q2 2026-08-06 -- ±10.36% -18.55% (beat)
2026/Q1 2026-05-07 -- ±18.26% +7.72% (in line)
2025/Q4 2026-02-26 -- ±8.80% -3.34% (in line)
2025/Q3 2025-11-06 -- ±13.21% +13.42% (beat)
2025/Q2 2025-08-07 -- ±13.38% +10.72% (in line)
2025/Q1 2025-05-08 After close ±10.56% +5.94% (in line)
2024/Q4 2025-02-27 After close ±16.79% +2.22% (in line)
2024/Q3 2024-11-07 After close ±9.68% -7.35% (in line)
2024/Q2 2024-08-08 After close ±8.73% +0.51% (in line)
2024/Q1 2024-05-09 After close ±16.30% -16.80% (beat)
2023/Q4 2024-02-22 After close ±13.56% +10.79% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Collegium Pharmaceutical discussion 0 comments

Add a comment